The Arthus reaction in rodents: Species-specific requirement of complement

被引:46
作者
Szalai, AJ [1 ]
Digerness, SB
Agrawal, A
Kearney, JF
Bucy, RP
Niwas, S
Kilpatrick, JM
Babu, YS
Volanakis, JE
机构
[1] Univ Alabama Birmingham, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA
[4] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA
[5] BioCryst Pharmaceut, Birmingham, AL 35244 USA
[6] Biomed Sci Res Ctr A Fleming, Vari, Greece
关键词
D O I
10.4049/jimmunol.164.1.463
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We induced reverse passive Arthus (RPA) reactions in the skin of rodents and found that the contribution of complement to immune complex-mediated inflammation is species specific. Complement was found to be necessary in rats and guinea pigs but not in C57BL/6J mice. In rats, within 4 h after initiation of an RPA reaction, serum alternative pathway hemolytic titers decreased significantly below basal levels, whereas classical pathway titers were unchanged. Thus the dermal reaction proceeds coincident with systemic activation of complement. The serine protease inhibitor BCX 1470, which blocks the esterolytic and hemolytic activities of the complement enzymes Cls and factor D in vitro, also blocked development of RPA-induced edema in the rat. These data support the proposal that complement-mediated processes are of major importance in the Arthus reaction in rats and guinea pigs, and suggest that BCX 1470 will be useful as an anti-inflammatory agent in diseases where complement activation is known to be detrimental.
引用
收藏
页码:463 / 468
页数:6
相关论文
共 32 条
[1]  
BABU YS, 1998, Patent No. 55471
[2]   IMMUNE-COMPLEXES AND INFLAMMATION - A STUDY OF THE ACTIVITY OF ANTI-INFLAMMATORY DRUGS IN THE REVERSE PASSIVE ARTHUS REACTION IN THE RAT [J].
BAILEY, PJ ;
STURM, A .
BIOCHEMICAL PHARMACOLOGY, 1983, 32 (03) :475-481
[3]   SYSTEMATIC DISCOVERY AND EVALUATION OF COMPLEMENT INHIBITORS [J].
BAUMAN, N ;
BROCKMAN, JA ;
PEASE, BS ;
ELLIOTT, WJ ;
COLUCCI, DF .
IMMUNOPHARMACOLOGY, 1981, 3 (04) :317-324
[4]  
BENACERRAF B, 1950, J IMMUNOL, V64, P1
[5]  
CARTER GW, 1982, RES COMMUN CHEM PATH, V35, P189
[6]   Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis [J].
Clynes, R ;
Dumitru, C ;
Ravetch, JV .
SCIENCE, 1998, 279 (5353) :1052-1054
[7]  
COCHRANE CG, 1970, J IMMUNOL, V105, P55
[8]  
FISCHEL EE, 1947, J IMMUNOL, V55, P337
[9]   ISOLATION OF HUMAN-COMPLEMENT COMPONENT-C3 FROM SMALL VOLUMES OF PLASMA [J].
GRESHAM, HD ;
MATTHEWS, DF ;
GRIFFIN, FM .
ANALYTICAL BIOCHEMISTRY, 1986, 154 (02) :454-459
[10]   Impaired IgG-dependent anaphylaxis and arthus reaction in Fc gamma RIII (CD16) deficient mice [J].
Hazenbos, WLW ;
Gessner, JE ;
Hofhuis, FMA ;
Kuipers, H ;
Meyer, D ;
Heijnen, IAFM ;
Schmidt, RE ;
Sandor, M ;
Capel, PJA ;
Daeron, M ;
vandeWinkel, JGJ ;
Verbeek, JS .
IMMUNITY, 1996, 5 (02) :181-188